Back to Search
Start Over
Abnormal DNA Methylation Induced by Hyperglycemia Reduces CXCR4 Gene Expression in CD34 + Stem Cells
- Source :
- Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
- Publication Year :
- 2019
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2019.
-
Abstract
- Background CD 34 + stem/progenitor cells are involved in vascular homeostasis and in neovascularization of ischemic tissues. The number of circulating CD 34 + stem cells is a predictive biomarker of adverse cardiovascular outcomes in diabetic patients. Here, we provide evidence that hyperglycemia can be “memorized” by the stem cells through epigenetic changes that contribute to onset and maintenance of their dysfunction in diabetes mellitus. Methods and Results Cord‐blood–derived CD 34 + stem cells exposed to high glucose displayed increased reactive oxygen species production, overexpression of p66 shc gene, and downregulation of antioxidant genes catalase and manganese superoxide dismutase when compared with normoglycemic cells. This altered oxidative state was associated with impaired migration ability toward stromal‐cell–derived factor 1 alpha and reduced protein and mRNA expression of the C‐X‐C chemokine receptor type 4 ( CXCR 4) receptor. The methylation analysis by bisulfite Sanger sequencing of the CXCR 4 promoter revealed a significant increase in DNA methylation density in high‐glucose CD 34 + stem cells that negatively correlated with mRNA expression (Pearson r =−0.76; P =0.004). Consistently, we found, by chromatin immunoprecipitation assay, a more transcriptionally inactive chromatin conformation and reduced RNA polymerase II engagement on the CXCR 4 promoter. Notably, alteration of CXCR 4 DNA methylation, as well as transcriptional and functional defects, persisted in high‐glucose CD 34 + stem cells despite recovery in normoglycemic conditions. Importantly, such an epigenetic modification was thoroughly confirmed in bone marrow CD 34 + stem cells isolated from sternal biopsies of diabetic patients undergoing coronary bypass surgery. Conclusions CD 34 + stem cells “memorize” the hyperglycemic environment in the form of epigenetic modifications that collude to alter CXCR 4 receptor expression and migration.
- Subjects :
- CD34 stem cells
CD34
Antigens, CD34
Coronary Artery Disease
metabolic memory
030204 cardiovascular system & hematology
CXCR4
Epigenesis, Genetic
Neovascularization
0302 clinical medicine
Gene expression
Coronary Heart Disease
Medicine
Coronary Artery Bypass
Original Research
0303 health sciences
DNA methylation
biology
histone modifications
Stem Cells
Middle Aged
Catalase
Up-Regulation
Histone
RNA Polymerase II
Stem cell
medicine.symptom
Cardiology and Cardiovascular Medicine
Chromatin Immunoprecipitation
Receptors, CXCR4
Src Homology 2 Domain-Containing, Transforming Protein 1
cardiovascular complications
Down-Regulation
Bone Marrow Cells
In Vitro Techniques
Pathophysiology
03 medical and health sciences
Vascular Biology
Diabetes Mellitus
Humans
RNA, Messenger
Progenitor cell
Aged
030304 developmental biology
Superoxide Dismutase
business.industry
Chemokine CXCL12
Gene Expression Regulation
Hyperglycemia
Cancer research
biology.protein
Reactive Oxygen Species
business
Basic Science Research
Subjects
Details
- ISSN :
- 20479980
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Journal of the American Heart Association
- Accession number :
- edsair.doi.dedup.....d6f3a0a33f14ef5394f2200932454672
- Full Text :
- https://doi.org/10.1161/jaha.118.010012